Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland

European Journal of Human Genetics

Volumn 13, Issue 7, 2005, Pages 829-834

  Dubaniewics, Anna ^a   Jamieson, Sarra E ^b   Dubaniewicz Wybieralska, M ^a   Fakiola, Michaela ^b   Miller, Nancy E ^b   Blackwell, Jenefer M ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Sarcoidosis; SLC11A1 (formerly NRAMP1); Tuberculosis

Indexed keywords

NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE REPEAT; POLAND; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SARCOIDOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULOSIS;

ADULT; AGED; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; MALE; MIDDLE AGED; POLAND; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SARCOIDOSIS; TUBERCULOSIS, PULMONARY;

EID: 21744458248     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201370     Document Type: Article

References (43)

1. Statement on sarcoidosis: Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-755.
2. Hunninghake GW, Crystal RG: Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes. J Clin Invest 1981; 67: 86-92.
3. Weinberg I, Vasiliev L, Gotsman I: Anti-dsDNA antibodies in sarcoidosis. Semin Arthritis Rheum 2000; 29: 328-331.
4. Negri C, Scovassi AI, Cerino A et al: Autoantibodies to poly(ADP-ribose)polymerase in autoimmune diseases. Autoimmunity 1990; 6: 203-209.
5. Pilatte Y, Tisserand EM, Greffard A et al: Anticarbohydrate autoantibodies to sialidase-treated erythrocytes and thymocytes in serum from patients with pulmonary sarcoidosis. Am J Med 1990; 88: 486-492.
6. DeRemee RA: Sarcoidosis and Wegener's granulomatosis: a comparative analysis. Sarcoidosis 1994; 11: 7-18.
7. Karlish AJ, MacGregor GA: Sarcoidosis, thyroiditis, and Addison's disease. Lancet 1970; 2: 330-333.
8. Seinfeld ED, Sharma OP: TASS syndrome: unusual association of thyroiditis, Addison's disease, Sjogren's syndrome and sarcoidosis. J Roy Soc Med 1983; 76: 883-885.
9. Papadopoulos KI, Hallengren B: Polyglandular autoimmune syndrome type III associated with coeliac disease and sarcoidosis. Postgrad Med J 1993; 69: 72-75.
10. Hanngren A, Odham G, Eklund A et al: Tuberculostearic acid in lymph nodes from patients with sarcoidosis. Sarcoidosis 1987; 4: 101-104.
11. Almenoff PL, Johnson A, Lesser M, Mattman LH: Growth of acid fast L forms from the blood of patients with sarcoidosis. Thorax 1996; 51: 530-533.
12. Lyons DJ, Fielding JF: What's in a relationship? Sarcoidosis and tuberculosis. Irish Med J 1990; 83: 76-79.
13. Rook G, McCulloch J: HLA-DR4, mycobacteria, heat-shock proteins, and rheumatoid arthritis. Arthritis Rheum 1992; 35: 1409-1412.
14. Rook GA, Adams V, Hunt J et al: Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders. Springer Semin Immunopathol 2004; 25: 237-255.
15. Classen JB, Classen DC: Immunization in the first month of life may explain decline in incidence of IDDM in The Netherlands. Autoimmunity 1999; 31: 43-45.
16. Classen DC, Classen JB: The timing of pediatric immunization and the risk of insulin-dependent diabetes mellitus. Infect Dis Clin Pract 1997; 6: 449-454.
17. Sanjeevi CB, Das AK, Shtauvere-Brameus A: BCG vaccination and GAD65 and IA-2 autoantibodies in autoimmune diabetes in southern India. Ann NY Acad Sci 2002; 958: 293-296.
18. Blackwell JM, Searle S, Mohamed H, White JK: Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Itv/Lsh/Bcg/Nramp1/Slc11a1 gene story. Immunol Lett 2003; 85: 197-203.
19. Blackwell JM, Barton CH, White JK et al: Genomic organization and sequence of the human NRAMP gene: identification and mapping of a promoter region polymorphism. Mol Med 1995; 1: 194-205.
20. Searle S, Blackwell JM: Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility. J Med Genet 1999; 36: 295-299.
21. n repeat: opposite effect in the presence of -237C→-T. Blood Cells Mol Dis 2004; 33: 45-50.
22. Donninger H, Cashmore TJ, Scriba T et al: Functional analysis of novel SLC11A1 (NRAMP1) promoter variants in susceptibility to HIV-1. J Med Genet 2004; 41: e49.
23. Shaw M-A, Clayton D, Atkinson SE et al: Linkage of rheumatoid arthritis to the candidate gene NRAMP1 on 2q35. J Med Genet 1996; 33: 672-677.
24. Sanjeevi CB, Miller EN, Dabadghao P et al: Polymorphism at NRAMP1 and D2S1471 loci associated with juvenile rheumatoid arthritis. Arthritis Rheum 2000; 43: 1397-1404.
25. Bellamy R, Ruwende C, Corrah T et al: Variation in the NRAMP1 gene is associated with susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338: 640-644.
26. Hoal van Helden EG, Lewis L-A, Tanzer F et al: SLC11A1 (NRAMP1) but not SLC11A2 (NRAMP2) polymorphisms are associated with susceptibility to tuberculosis in a high incidence community in South Africa. Int J Tuberc Lung Dis 2004; 8: 1464-1471.
27. Gao PS, Fujishima S, Mao XQ et al: Genetic variants of NRAMP1 and active tuberculosis in Japanese populations. International Tuberculosis Genetics Team. Clin Genet 2000; 58: 74-76.
28. Ma X, Dou S, Wright JA et al: 5′ dinucleotide repeat polymorphism of NRAMP1 and susceptibility to tuberculosis among Caucasian patients in Houston, Texas. Int J Tuberc Lung Dis 2002; 6: 818-823.
29. Liu J, Fujiwara TM, Buu NT et al: Identification of polymorphisms and sequence variants in human homologue of the mouse natural resistance-associated macrophage protein gene. Am J Hum Genet 1995; 56: 845-853.
30. Lewis L-A, Victor T, Hoal-van Helden E et al: Identification of a C to T mutation at position -236bp in the human NRAMP1 promoter. Immunogenetics 1996; 44: 309-311.
31. Mohamed HS, Ibrahim ME, Miller EN et al: SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan. Eur J Hum Genet 2004; 12: 66-74.
32. Buu NT, Cellier M, Gros P, Schurr E: Identification of a highly polymorphic length variant in the 3′UTR of NRAMP1. Immunogenetics 1995; 42: 428-429.
33. Awomoyi AA, Marchant A, Howson JM et al: Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. J Infect Dis 2002; 186: 1804-1814.
34. Cervino AC, Lakiss S, Sow O, Hill AV: Allelic association between the NRAMP1 gene and susceptibility to tuberculosis in Guinea-Conakry. Ann Hum Genet 2000; 64: 507-512.
35. Greenwood CM, Fujiwara TM, Boothroyd LJ et al: Linkage of tuberculosis to chromosome 2q3S loci, including NRAMP1, in a large aboriginal Canadian family. Am J Hum Genet 2000; 67: 405-416.
36. Shaw M-A, Collins A, Peacock CS et al: Evidence that genetic susceptibility to Mycobacterium tuberculosis in a Brazilian population is under oligogenic control: linkage study of the candidate genes NRAMP1 and TNFA. Tuberc Lung Dis 1997; 78: 35-45.
37. Ryu S, Park YK, Bai GH et al: 3′UTR polymorphisms in the NRAMP1 gene are associated with susceptibility to tuberculosis in Koreans. Int J Tuberc Lung Dis 2000; 4: 577-580.
38. Delgado JC, Baena A, Thim S, Goldfeld AE: Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis 2002; 186: 1463-1468.
39. Liu W, Cao WC, Zhang CY et al: VDR and NRAMP1 gene polymorphisms in susceptibility to pulmonary tuberculosis among the Chinese Han population: a case-control study. Int J Tuberc Lung Dis 2004; 8: 428-434.
40. Liaw YS, Tsai-Wu JJ, Wu CH et al: Variations in the NRAMP1 gene and susceptibility of tuberculosis in Taiwanese. Int J Tuberc Lung Dis 2002; 6: 454-460.
41. El Baghdadi J, Remus N, Benslimane A et al: Variants of the human NRAMP1 gene and susceptibility to tuberculosis in Morocco. Int J Tuberc Lung Dis 2003; 7: 599-602.
42. Maliarik MJ, Chen KM, Sheffer RG et al: The natural resistance-associated macrophage protein gene in African Americans with sarcoidosis. Am J Respir Cell Mol Biol 2000; 22: 672-675.
43. Akahoshi M, Ishihara M, Remus N et al: Association between IFNA genotype and the risk of sarcoidosis. Hum Genet 2004; 114: 503-509.